The diagnosis of late life hypogonadism

References

• Morley J E, Perry H M, III. Androgen deficiency in aging men: role of testosterone replacement therapy. J Lab Clin Med 2000; 135: 370–378
   PubMed Web of Science ®Google Scholar
• Groopman J. Hormones for Men (public awareness campaign launched to help in recognition of symptoms of male menopause or andropause). New Yorker. July 29, 2002
   Google Scholar
• Nieschlag E, Swerdloff R, Behre H M, Gooren L J, Kaufman J M, Legros J J, Lunenfeld B, Morley J E, Schulman C, Wang C, Weidner W, Wu F C. Investigation, treatment and monitoring of late-onset hypogonadism in males. Aging Male 2005; 8: 56–58
   PubMedGoogle Scholar
• Bhasin S, Cunningham G R, Hayes F J, Matsumoto A M, Snyder P J, Swerdloff R S, Montori V M. Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2006; 91: 1995–2010
   PubMed Web of Science ®Google Scholar
• Shores M M, Moceri V M, Sloan K L, Matsumoto A M, Kivlahan D R. Low testosterone levels predict incident depressive illness in older men: effects of age and medical morbidity. J Clin Pyschiatry 2005; 66: 7–14
   PubMed Web of Science ®Google Scholar
• Morley J E, Kim M J, Haren M T, Kevorkian R, Banks W A. Frailty and the aging male. Aging Male 2005; 8: 135–140
   PubMed Web of Science ®Google Scholar
• Lunenfeld B, Saad F, Hoesl C E. ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale. Aging Male 2005; 8: 59–74
   PubMedGoogle Scholar
• Morales A, Tenover J L. Androgen deficiency in the aging male: when, who, and how to investigate and treat. Urol Clin North Am 2002; 29: 975–982
   PubMed Web of Science ®Google Scholar
• Morley J E, Baumgartner R N, Roubenoff R, Mayer J, Nair K S. Sarcopenia. J Lab Clin Med 2001; 137: 231–243
   PubMed Web of Science ®Google Scholar
• Morley J E, Charlton E, Patrick P, Kaiser F E, Cadeau P, McCready D, Perry H M, III. Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism 2000; 49: 1239–1242
   PubMed Web of Science ®Google Scholar
• Lin Y C, Hwang T I, Chiang H S, Yang C R, Wu H C, Wu T L, Huang S P. Correlations of androgen deficiency with clinical symptoms in Taiwanese males. Int J Impot Res 2006; 18: 343–347
   PubMedGoogle Scholar
• Tancredi A, Reginster J Y, Schleich F, Pire G, Maassen P, Luyckx F, Legros J J. Interest of the androgen deficiency in aging males (ADAM) questionnaire for the identification of hypogonadism in elderly community-dwelling male volunteers. Eur J Endocrinol 2004; 151: 355–360
   PubMed Web of Science ®Google Scholar
• Morley J E, Perry H M, III, Kevorkian R T, Patrick P. Comparison of screening questionnaires for the diagnosis of hypogonadism. Maturitas 2006; 53: 424–429
   PubMed Web of Science ®Google Scholar
• Miwa Y, Kaneda T, Yokoyama O. Correlation between the Aging Males' Symptoms Scale and sex steroids, gonoadotropins, dehydroepiandrosterone sulfate, and growth hormone levels in ambulatory men. J Sex Med 2006; 3: 723–726
   PubMed Web of Science ®Google Scholar
• Heinemann L A, Saad F, Heinemann K, Thai D M. Can results of the Aging Males' Symptoms (AMS) scale predict those of screening scales for androgen deficiency?. Aging Male 2004; 7: 211–218
   PubMedGoogle Scholar
• Myon E, Martin N, Taieb C, Heinemann L A. Experiences with the French Aging Males' Symptoms (AMS) scale. Aging Male 2005; 8: 184–189
   PubMedGoogle Scholar
• Handelsman D J. Testosterone: use, misuse and abuse. Med J Aust 2006; 185: 436–439
   PubMed Web of Science ®Google Scholar
• Kelleher S, Conway A J, Handelsman D J. Blood testosterone threshold for androgen deficiency symptoms. J Clin Endocrinol Metab 2004; 89: 3813–3817
   PubMed Web of Science ®Google Scholar
• Zitzmann M, Faber S, Nieschlag E. Association of specific symptoms and metabolic risks with serum testosterone in older men. J Clin Endocrinol Metab 2006; 91: 4335–4343
   PubMed Web of Science ®Google Scholar
• Travison T G, Morley J E, Araujo A B, O'Donnell A B, McKinlay J B. The relationship between libido and testosterone levels in aging men. J Clin Endocrinol Metab 2006; 91: 2509–2513
   PubMed Web of Science ®Google Scholar
• Isidori A M, Giannetta E, Gianfrilli D, Greco E A, Bonifacio V, Aversa A, Isidori A, Febbri A, Lenzi A. Effects of testosterone on sexual function in men: results of a meta-analysis. Clin Endocrinol 2005; 63: 601–602
   PubMed Web of Science ®Google Scholar
• Shabsigh R, Kaufman J M, Steidle C, Padma-Nathan H. Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. J Urol 2004; 172: 658–663
   PubMed Web of Science ®Google Scholar
• Greenstein A, Mabjeesh N J, Sofer M, Kaver I, Matzkin H, Chen J. Does sildenafil combined with testosterone gel improve erectile dysfunction in hypogonadal men in whom testosterone supplement therapy alone failed?. J Urol 2005; 173: 530–532
   PubMed Web of Science ®Google Scholar
• Shabsigh R. Testosterone therapy in erectile dysfunction. Aging Male 2004; 7: 312–318
   PubMedGoogle Scholar
• Tariq S H, Haleem U, Omran M L, Kaiser F E, Perry H M, III, Morley J E. Erectile dysfunction: etiology and treatment in young and old patients. Clin Geriatr Med 2003; 19: 539–551
   PubMedGoogle Scholar
• Morley J E, Melmed S. Gonadal dysfunction in systematic disorders. Metabolism 1979; 28: 1051–1073
   PubMed Web of Science ®Google Scholar
• Morley J E, Kaiser F E, Perry H M, III, Patrick P, Morley P M, Stauber P M, Vellas B, Baumgartner R N, Garry P J. Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metabolism 1997; 46: 410–413
   PubMed Web of Science ®Google Scholar
• Zmuda J M, Cauley J A, Kriska A, Glynn N W, Gutai J P, Kuller L H. Longitudinal relation between endogenous testosterone and cardiovascular disease risk factors in middle-aged men. A 13-year follow-up of former Multiple Risk Factor Intervention Trial participants. Am J Epidemiol 1997; 146: 609–617
   PubMed Web of Science ®Google Scholar
• Harman S M, Metter E J, Tobin J D, Pearson J, Blackman M R, Baltimore Longitudinal Study of Aging. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J Clin Endocrinol Metab 2001; 86: 724–731
   PubMed Web of Science ®Google Scholar
• Feldman H A, Longcope C, Derby C A, Johannes C B, Araujo A B, Coviello A D, Bremner W J, McKinlay J B. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts Male Aging Study. J Clin Endocrinol Metab 2002; 87: 589–598
   PubMed Web of Science ®Google Scholar
• Spratt D I, O'Dea L S, Schoenfeld D, Butler J, Rao P N, Crowley W F, Jr. Neuroendocrine-gonadal axis in men: frequent sampling of LH, FSH, and testosterone. Am J Physiol 1988; 254: E658–E666
   Google Scholar
• Diver M J, Imtiaz K E, Ahmad A M, Vora J P, Fraser W D. Diurnal rhythms of serum total, free and bioavailable testosterone and of SHBG in middle-aged men compared with those in young men. Clin Endocrinol 2003; 58: 710–717
   PubMed Web of Science ®Google Scholar
• Plymate S R, Tenover J S, Bremner W J. Circadian variation in testosterone, sex hormone-binding globulin, and calculate non-sex hormone-binding globulin bound testosterone in health young and elderly men. J Androl 1989; 10: 366–371
   PubMed Web of Science ®Google Scholar
• Morley J E, Patrick P, Perry H M, III. Evaluation of assays available to measure free testosterone. Metabolism 2002; 51: 554–559
   PubMed Web of Science ®Google Scholar
• Vermeulen A, Verdonck G. Representativeness of a single point plasma testosterone level for the long term hormonal milieu in men. J Clin Endocrinol Metab 1992; 74: 939–942
   PubMedGoogle Scholar
• Lazarou S, Reyes-Vallejo L, Morgentaler A. Wide variability in laboratory reference values for serum testosterone. J Sex Med 2006; 3: 1085–1089
   PubMed Web of Science ®Google Scholar
• Wang C, Catlin D H, Demers L M, Starcevic B, Swerdloff R S. Measurement of total serum testosterone in adult men: comparison of current laboratory methods versus liquid chromatography-tandem mass spectrometry. J Clin Endocrinol Metab 2004; 89: 634–643
   Google Scholar
• Rosner W, Auchus R J, Azziz R, Sluss P M, Raff H. Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab 2007; 92: 405–413
   PubMed Web of Science ®Google Scholar
• Matsumoto A M. Andropause: clinical implications of the decline in serum testosterone levels with aging in men. J Gerontol A Biol Sci Med Sci 2002; 57: M76–M99
   PubMed Web of Science ®Google Scholar
• Morley J E. Androgens and aging. Maturitas 2001; 38: 61–71
   PubMed Web of Science ®Google Scholar
• Nankin H R, Calkins J H. Decreased bioavailable testosterone in aging normal and impotent men. J Clin Endocrinol Metab 1986; 63: 1418–1420
   PubMed Web of Science ®Google Scholar
• Vermeulin A, Kaufman J M. Diagnosis of hypogonadism in the aging male. Aging Male 2002; 5: 170–176
   PubMedGoogle Scholar
• Christ-Crain M, Meier C, Huber P, Zimmerli L, Trummler M, Muller B. Comparison of different methods for the measurement of serum testosterone in the aging male. Swiss Med Wkly 2004; 134: 193–197
   PubMedGoogle Scholar
• Vermeulen A, Verdonck L, Kaufman J M. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999; 84: 3666–3672
   PubMed Web of Science ®Google Scholar
• van den Beld A W, de Jong F H, Grobbee D E, Pols H A, Lamberts S W. Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. J Clin Endocrinol Metab 2000; 85: 3276–3282
   PubMed Web of Science ®Google Scholar
• Wang C, Plymate S, Nieschlag E, Paulsen C A. Salivary testosterone in men: further evidence of a direct correlation with free serum testosterone. J Clin Endocrinol Metab 1981; 53: 1021–1024
   PubMed Web of Science ®Google Scholar
• Morley J E, Perry H M, III, Patrick P, Dollbaum C M, Kells J M. Validation of salivary testosterone as a screening test for male hypogonadism. Aging Male 2006; 9: 165–169
   PubMed Web of Science ®Google Scholar
• Gonacharov N, Katsya G, Dobracheva A, Nizhnik A, Kolesnikova G, Herbst V, Westermann J. Diagnostic significance of free salivary testosterone measurement using a direct luminescence immunoassay in healthy men and in patients with disorders of androgenic status. Aging Male 2006; 9: 111–122
   PubMedGoogle Scholar
• Tenover J S. Effects of testosterone supplementation in the aging male. J Clin Endocrinol Metab 1992; 75: 1092–1098
   PubMed Web of Science ®Google Scholar
• Morley J E, Perry H M, III, Kaiser F E, Kraenzle D, Jensen J, Houston K, Mattammal M, Perry H M, III. Effects of testosterone replacement therapy in old hypogonadal males: re preliminary study. J Am Geriatr Soc 1993; 41: 149–152
   PubMed Web of Science ®Google Scholar
• Sih R, Morley J E, Kaiser F E, Perry H M, III, Patrick P, Ross C. Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. J Clin Endocrinol Metab 1997; 82: 1661–1667
   PubMed Web of Science ®Google Scholar
• Bolona E R, Uraga M V, Haddad R M, Tracz M J, Sideras K, Kennedy C C, Caples S M, Erwin P J, Montori V M. Testosterone use in men with sexual dysfunction: a systematic review and meta-analysis of randomized placebo-controlled trials. Mayo Clin Proc 2007; 82: 20–28
   PubMed Web of Science ®Google Scholar
• Ottenbacher K J, Ottenbacher M E, Ottenbacher A J, Acha A A, Ostir G V. Androgen treatment and muscle strength in elderly men: a meta-analysis. J Am Geriatr Soc 2006; 54: 1666–1673
   PubMed Web of Science ®Google Scholar
• Isidori A M, Giannetta E, Greco E A, Gianfrilli D, Bonifacio V, Isidori A, Lenzi A, Fabbri A. Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis. Clin Endocrinol 2005; 63: 280–293
   PubMed Web of Science ®Google Scholar
• Page S T, Amory J K, Bowman F D, Anawalt B D, Matsumoto A M, Bremner W J, Tenover J L. Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. J Clin Endocrinol Metab 2005; 90: 1502–1510
   PubMed Web of Science ®Google Scholar
• Haren M T, Wittert G A, Chapman I M, Coates P, Morley J E. Effect of oral testosterone undecanoate on visuospatial cognition, mood and quality of life in elderly men with low-normal gonadal status. Maturitas 2005; 50: 124–133
   PubMed Web of Science ®Google Scholar
• Hajjar R R, Kaiser F E, Morley J E. Outcomes of long-term testosterone replacement in older hypogonadal males: retrospective analysis. J Clin Endocrinol Metab 1997; 82: 3793–3796
   PubMed Web of Science ®Google Scholar
• Haddad R M, Kennedy C C, Caples S M, Tracz M J, Bolona E R, Sideras K, Uraga M V, Erwin P J, Montori V M. Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials. Mayo Clin Proc 2007; 82: 29–39
   PubMed Web of Science ®Google Scholar
• Calof O M, Singh A B, Lee M L, Kenny A M, Urban R J, Tenover J L, Bhasin S. Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials. J Gerontol A Biol Sci Med Sci 2005; 60: 1451–1457
   PubMed Web of Science ®Google Scholar
• Stein D J, Baldwin D S, Dolberg O T, Despiegel N, Bandelow B. Which factors predict placebo response in anxiety disorders and major depression? An analysis of placebo-controlled studies of escitalopram. J Clin Psychiatry 2006; 67: 1741–1746
   PubMed Web of Science ®Google Scholar
• Haren M T, Kim M J, Tariq S H, Wittert G A, Morley J E. Andropause: a quality-of-life issue in older males. Med Clin North Am 2006; 90: 1005–1023
   PubMed Web of Science ®Google Scholar